AI Article Synopsis

  • A study was conducted in Denmark to assess the awareness of the teratogenic risks associated with oral retinoids and the adherence to pregnancy prevention programs (PPP) among healthcare providers and patients.
  • Surveys were distributed to dermatologists, general practitioners, pharmacists, and women of childbearing age using oral retinoids, revealing high awareness levels of teratogenicity (95-100%) across the groups.
  • Despite this awareness, there was inconsistent adherence to PPP measures, indicating a need for improved accessibility and encouragement of certain safety practices, especially those requiring patient signatures.

Article Abstract

Purpose: We aimed to investigate the awareness of oral retinoid teratogenicity and the adherence to the pregnancy prevention program (PPP) related to oral retinoid use by physicians, pharmacists, and patients in Denmark.

Methods: As part of the multi-country survey, web-based questionnaires were distributed among Danish dermatologists, general practitioners, community pharmacists, and women of childbearing age, who were using or had used oral retinoids within the past 5 years.

Results: A total of 62 physicians, 96 pharmacists, and 50 oral retinoid using women responded; 95%, 100%, and 98%, respectively, were aware of the teratogenic risks of oral retinoids. For physicians, the most applied PPP measures were the usage of the patient (44%) and the healthcare professional (19%) guides, while the least applied measure was signing medication risk awareness form (3%). Among the pharmacists, the warning sign on the outer medication package was the most used measure (45%). Among the women, a majority (90%) had read the patient information leaflet included in the medication package and 72% discussed the use of contraception with their healthcare provider, while risk awareness forms and patient cards were seen by only few.

Conclusions: In Denmark, physicians, pharmacists, and medicine users were aware about the teratogenic effects of oral retinoids. Adherence to pregnancy prevention measures varied, suggesting unwillingness to use the measures that require patients' signatures among physicians and a lack of awareness of pharmacy targeting measures. Accessibility of the latter measures need to be optimized to improve the safety of oral retinoid use.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.70023DOI Listing

Publication Analysis

Top Keywords

oral retinoids
16
oral retinoid
16
adherence pregnancy
12
physicians pharmacists
12
pregnancy prevention
8
prevention program
8
oral
8
aware teratogenic
8
risk awareness
8
medication package
8

Similar Publications

Introduction: Oral lichen planus (OLP) is a chronic inflammatory mucocutaneous condition that includes a spectrum of oral clinical manifestations ranging from mild painless white lesions to painful erosions and ulcers. The purpose of this European multicenter study is to describe the general characteristics of OLP lesions, the clinical and histopathological diagnosis, and the management of OLP at different European Oral Medicine and Maxillofacial Surgery centers, in order to minimize selections biases and provide information about the current trends in the treatment of OLP across Europe.

Materials And Methods: Data and histopathological records of patients with OLP were retrospectives revised and only those patients that fulfilled the diagnostic criteria from the 2016 position paper by American Academy of Oral and Maxillofacial Pathology were included.

View Article and Find Full Text PDF
Article Synopsis
  • This review analyzes the effects of oral retinoids like isotretinoin on wound healing across different surgical fields.
  • It raises concerns about the common practice of stopping these medications before surgery, suggesting it's not always necessary based on current research.
  • The article calls for personalized decisions regarding retinoid use before surgery and highlights the importance of collaboration between dermatologists and surgeons for better perioperative care.
View Article and Find Full Text PDF

Maintenance Acne Treatment with Topical Tazarotene after Oral Isotretinoin: Overview and Case Reports.

J Clin Aesthet Dermatol

January 2024

Ms. Miranti is with Riverchase Dermatology and Cosmetic Surgery in Naples, Florida.

Acne is a chronic dermatologic disorder that can require long-term treatment. To prevent recurrence after oral treatment for severe acne, topical maintenance treatment is recommended; however, there is little guidance or research on maintenance regimens. This article briefly summarizes literature on oral isotretinoin and topical retinoids and presents a case series of patients who received tazarotene 0.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines the effects of oral isotretinoin on eye health in patients with acne vulgaris, highlighting issues like dryness and discomfort.
  • A survey of 489 participants showed a high prevalence of ocular symptoms linked to isotretinoin use, with notable findings including a majority experiencing soreness and blurred vision.
  • Key risk factors for worsening eye symptoms included contact lens use and higher isotretinoin dosages, suggesting the need for careful monitoring and preventive measures for patients at risk.
View Article and Find Full Text PDF

Acute promyelocytic leukaemia (APL) is a highly lethal haematological malignancy. It is rare in pregnancy and may be fatal if not managed promptly and appropriately. A woman in her 20s presented with high-grade fever at 16 weeks of her third pregnancy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!